Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women
Tóm tắt
Menstrual, reproductive and contraceptive factors have been associated with risk of endometrial cancer in populations where the incidence of this tumor is high. To investigate associations between these factors in a low-risk population with a low prevalence of hormone replacement therapy, we conducted a cohort study among 267,400 women employed in the textile industry in Shanghai, China. Menstrual, reproductive and other factors were ascertained at baseline in 1989–1991, and women were followed for incident endometrial cancer through 31 December 1998 (n = 206). Cox proportional hazards modeling was used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Risk of endometrial cancer decreased with increasing age at menarche (p-trend = 0.004). Among menopausal women, risk increased with age at menopause and increasing years of menstruation. Compared to women with one live birth, risk was increased in relation to nulliparity (Hazard ratio = 3.95, 95% CI 1.43–10.86). Risk was decreased with increasing age at first live birth (p-trend = 0.03). There was a decreased risk associated with ever use of an intrauterine device (HR = 0.56, 95% CI 0.35–0.88) and use of oral contraceptives for ≥2 years (HR = 0.50, 95% CI 0.23–1.07). This prospective study confirms findings from previous case–control studies relating menstrual, reproductive, and contraceptive factors and endometrial carcinoma.
Tài liệu tham khảo
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Jin F, Devesa SS, Chow WH, et al (1999) Cancer incidence trends in urban shanghai, 1972–1994: an update. Int J Cancer 83(4):435–440
Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P (2001) Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann NY Acad Sci 943:296–315
Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21(3):427–433
Grady D, Ernster VL (1996) Endometrial cancer. In: Schottenfeld D, Fraumeni JF, Jr (eds). Cancer epidemiology, prevention. 2nd edn. Oxford University Press, New York City pp 1058–1089
Xu WH, Xiang YB, Ruan ZX, et al (2004) Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer 108(4):613–619
Pettersson B, Adami HO, Bergstrom R, Johansson ED (1986) Menstruation span—a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand 65(3):247–255
Parazzini F, Negri E, La Vecchia C, et al (1998) Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 76(6):784–786
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505
The WHO Collaborative Study of Neoplasia, Steroid Contraceptives (1991) Depot-medroxyprogesterone acetata (DMPA) and risk of endometrial cancer. Int J Cancer 49:186–190
Xu WH, Xiang YB, Zheng W, et al (2006) Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 35(1):159–166
Thomas DB, Gao DL, Self SG, et al (1997) Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst 89(5):355–365
Thomas DB, Gao DL, Ray RM, et al (2002) Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 94(19):1445–1457
Wernli KJ, Ray RM, Gao DL, Thomas DB, Checkoway H (2003) Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989–1998. Am J Ind Med 44(6):595–599
Breslow NE, Day NE (1987) Statistical methods in cancer research. IARC Lyon, France
Mogren I, Stenlund H, Hogberg U (2001) Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 40(7):849–854
Kalandidi A, Tzonou A, Lipworth L, Gamatsi I, Filippa D, Trichopoulos D (1996) A case–control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology 53(5):354–359
Parslov M, Lidegaard O, Klintorp S, et al (2000) Risk factors among young women with endometrial cancer: a Danish case–control study. Am J Obstet Gynecol 182(1 Pt 1):23–29
Lambe M, Wuu J, Weiderpass E, Hsieh CC (1999) Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes Control 10(1):43–49
Kvale G, Heuch I, Ursin G (1988) Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res 48(21):6217–6221
Shu XO, Brinton LA, Zheng W, Gao YT, Fan J, Fraumeni JF Jr (1991) A population-based case–control study of endometrial cancer in Shanghai, China. Int J Cancer 49(1):38–43
Purdie DM, Green AC (2001) Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 15(3):341–354
IARC Working Group (2006) Combined estrogen–progestogen contraceptives, vol 91. IARC Press, Lyon
Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N (2002) IUD use and the risk of endometrial cancer. Eur J Obstet Gynecol Reprod Biol 105(2):166–169
Hill DA, Weiss NS, Voigt LF, Beresford SA (1997) Endometrial cancer in relation to intra-uterine device use. Int J Cancer 70(3):278–281
Sturgeon SR, Brinton LA, Berman ML, et al (1997) Intrauterine device use and endometrial cancer risk. Int J Epidemiol 26(3):496–500
Rosenblatt KA, Thomas DB (1996) Intrauterine devices and endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception 54(6):329–332
Stanford JB, Mikolajczyk RT (2002) Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 187(6):1699–1708
Guleria K, Agarwal N, Mishra K, Gulati R, Mehendiratta A (2004) Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer? J Obstet Gynaecol Res 30(3):181–187
Xiaoqin C, Li X, Xiaoping P, Chuanrong Z, Shiyuan L (2003) Survey of IUD replacing status in Sichuan, PR China. Contraception 67(5):379–383
Wang D, Altmann DR (2002) Socio-demographic determinants of intrauterine device use and failure in China. Hum Reprod 17(5):1226–1232
Gu D, Reynolds K, Wu X, et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365(9468):1398–1405
Xu WH, Matthews CE, Xiang YB, et al (2005) Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 161(10):939–947
Li W, Ray RM, Lampe JW, et al (2005) Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case–control study in Shanghai, China. Int J Cancer 115(6):981–993
Sherman ME, Carreon JD, Lacey JV Jr, Devesa SS (2005) Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 97(22):1700–1702
Chen P, Miller AE (1975) Lessons from the Chinese experience: China’s planned birth program and its transferability. Stud Fam Plann 6(10):354–366
Shen G (1984) A brief introduction to China’s family planning programme. China Popul Newslett 1(3):4–10